Most dementia patients have multiple brain diseases. How should they be treated?

AI Insight

Research increasingly shows that most dementia patients do not suffer from a single brain disease but rather from multiple simultaneous pathologies, a phenomenon known as "copathology." Common combinations include Alzheimer's disease alongside vascular damage, Lewy body pathology, or TDP-43 protein deposits. This recognition is reshaping how researchers understand dementia progression and why many patients respond poorly to treatments targeting only one disease mechanism.

Why it matters

The acknowledgment of copathology has direct consequences for clinical practice, as it is driving the development of new diagnostic tools capable of detecting multiple pathologies simultaneously and prompting clinical trials designed to test combination therapies rather than single-target interventions.